Neuro-Orthopedic Registry of the University Hospital of Toulouse

Neuro-orthopedics corresponds to the evaluation and therapeutic management of the orthopedic consequences of damage to the central or peripheral nervous system. In case of neurological impairment, there may be joint, motor, sensory and cognitive impairments that limit the patient's activities. The management of these orthopedic problems falls within the specific framework of neuro-orthopedics because in the presence of neurological, problems are different and more complex than in classical orthopedics. In this context, a well-conducted evaluation is a prerequisite for appropriate treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neurologic Disorder Nervous System Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Toulouse

Toulouse, Midi-Pyrénées, 31059, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with a neurological condition that benefits:

An injection of botulinum toxin in the context of spasticity : about 20 / week
Pre or post-therapeutic clinical evaluation (botulinum toxin or surgery): approximately 10 / week
Clinical or instrumental evaluation of the walking or upper limb (Physiological Functional Explorations): about 10 / week
A medical and surgical multidisciplinary consultation about spasticity : about 15 / month
A discussion during neuroorthopedic multidisciplinary consultation meeting about the patient's file and anomalies of walking: about 8 / month
Implementation of a Baclofen pump (Neurosurgery): about 2 / month
Functional surgery of the upper or lower limb (locomotor institute, orthopedic surgery and traumatology): about 4 / sem

Exclusion criteria

Patient (or the legal representative) who opposes the data collection.

Treatment and study plan

Data Collection

Other

data collection about symptoms without any specific clinical or biological intervention

Primary outcomes

Neurologic symptoms

Time frame: Each year until five years

Data collection

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Collaborators

Ipsen

Registry information

Important dates

Study start: 2014
Primary completion: 2019
Study completion: 2019
First posted: Nov 6, 2017
Registry last updated: Jul 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed